Company Filing History:

41 out of 1,384

Schering Aktiengesellschaft

patents

1 out of 1

Schering Aktiengeselleschaft

patent

1 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

Years Active: 1978-2001

Loading Chart...

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6225347 - 9-halogen-(Z)-prostaglandin derivatives, process for their production and their use as pharmaceutical agents (2001-05-01),

2. 5891910 - 9-halogen-(Z) prostaglandin derivatives, process for their production (1999-04-06),

3. 5523321 - Prostacyclins, their analogs or prostaglandins and thromboxane (1996-06-04),

4. 5204371 - Pharmaceutically active 9-chloroprostaglandins (1993-04-20),

5. 5190973 - 20-alkyl-7-oxoprostacyclin derivatives useful as pharmaceuticals (1993-03-02),

6. 5162353 - Carbacyclins, processes for their preparation, and their use as (1992-11-10),

7. 5157042 - 3-oxa-5-fluoro-carbacyclins, their preparation and use as medicinal (1992-10-20),

8. 5124343 - Carbacyclins, process for the preparation thereof, and use thereof as (1992-06-23),

9. 5093490 - Process for optical resolution of bicyclo[3.3.0]octane-3,7-dione-2 (1992-03-03),

10. 5079259 - Pharmaceutically active 9-chloroprostaglandins (1992-01-07),

11. 5013758 - Novel carbacyclins, processes for their preparation and their use as (1991-05-07),

12. 5010065 - Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use (1991-04-23),

13. 5004752 - Novel 9-haloprostaglandins, processes for their preparation, and their (1991-04-02),

14. 4971987 - New carbacycline, process for their production and their use as a drug (1990-11-20),

15. 4960907 - Process for the production of (1990-10-02),

Title: Helmut Vorbrueggen: A Prolific Innovator in Pharmaceutical Patents

Introduction

Helmut Vorbrueggen is a distinguished inventor based in Berlin, Germany. With an impressive portfolio of 43 patents, he has significantly contributed to the field of pharmaceuticals, particularly in the development of novel prostaglandin derivatives.

Latest Patents

Among his latest inventions are the 9-halogen-(Z)-prostaglandin derivatives. These unique compounds are described as 9-halogen-(Z) prostane derivatives represented by a specific formula. These innovations include a detailed process for their production and their use as pharmaceutical agents, highlighting their potential in medical applications.

Career Highlights

Vorbrueggen's career spans several notable organizations. He has worked with Schering Aktiengesellschaft, a renowned pharmaceutical company, and Kyowa Hakko Kogyo Co., Ltd., which is recognized for its contributions to biotechnology. His work in these companies has cemented his reputation as a leader in pharmaceutical research and innovation.

Collaborations

Throughout his career, Vorbrueggen has collaborated with esteemed colleagues, including Werner Skuballa and Bernd Raduechel. These partnerships have enabled him to leverage diverse expertise, further enhancing the impact of his inventions.

Conclusion

Helmut Vorbrueggen's innovative spirit and dedication to pharmaceutical research are evident through his numerous patents and collaborative efforts. His work continues to influence the field, paving the way for future advancements in pharmaceutical applications.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.